TransMedics: 3 Key Takeaways for Long-Term Investors
Its ENHANCE heart and DENOVO lung programs target thousands of procedures that currently use no machine preservation at all.
Full story
Read the full story at The Motley Fool ↗
Continue reading this story on The Motley Fool, the publisher that reported it.
AI tools
Written by AI from the article text. It can make mistakes; check the original story.
